Jasmin, Reyzon Raze C.
HRN: 23-15-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/19/2023
06/26/2023
TOPICAL
1ml
TID
Oral Sores
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes